These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


170 related items for PubMed ID: 1541827

  • 1. Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide.
    Zanetti G, Heumann D, Gérain J, Kohler J, Abbet P, Barras C, Lucas R, Glauser MP, Baumgartner JD.
    J Immunol; 1992 Mar 15; 148(6):1890-7. PubMed ID: 1541827
    [Abstract] [Full Text] [Related]

  • 2. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice.
    Starnes HF, Pearce MK, Tewari A, Yim JH, Zou JC, Abrams JS.
    J Immunol; 1990 Dec 15; 145(12):4185-91. PubMed ID: 2124237
    [Abstract] [Full Text] [Related]

  • 3. Human IgG but not IgM antibodies can protect mice from the challenge with live O6 Escherichia coli.
    Pontes GN, Massironi SG, Arslanian C, Palmeira P, Carneiro-Sampaio MM, Nagao AT.
    Scand J Immunol; 2005 Oct 15; 62(4):353-60. PubMed ID: 16253122
    [Abstract] [Full Text] [Related]

  • 4. Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis.
    Matsukawa A, Yoshimura T, Miyamoto K, Ohkawara S, Yoshinaga M.
    Lab Invest; 1997 May 15; 76(5):629-38. PubMed ID: 9166282
    [Abstract] [Full Text] [Related]

  • 5. Lymphocyte-derived cytokines augment macrophage tumor necrosis factor-alpha and interleukin-6 secretion during experimental gram-negative bacterial sepsis.
    Battafarano RJ, Kim SK, Dahlberg PS, Farber MS, Ratz CA, Johnston JW, Dunn DL.
    J Surg Res; 1995 Jun 15; 58(6):739-45. PubMed ID: 7791354
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-12 and -18 induce severe liver injury in mice recovered from peritonitis after sublethal endotoxin challenge.
    Ono S, Ueno C, Seki S, Matsumoto A, Mochizuki H.
    Surgery; 2003 Jul 15; 134(1):92-100. PubMed ID: 12874588
    [Abstract] [Full Text] [Related]

  • 7. Production of tumor necrosis factor-alpha and interleukin-6 in mice infected with group B streptococci.
    Teti G, Mancuso G, Tomasello F, Chiofalo MS.
    Circ Shock; 1992 Oct 15; 38(2):138-44. PubMed ID: 1423922
    [Abstract] [Full Text] [Related]

  • 8. IFN-gamma involvement in the severity of gram-negative infections in mice.
    Kohler J, Heumann D, Garotta G, LeRoy D, Bailat S, Barras C, Baumgartner JD, Glauser MP.
    J Immunol; 1993 Jul 15; 151(2):916-21. PubMed ID: 8335919
    [Abstract] [Full Text] [Related]

  • 9. The role of anti-tumor necrosis factor-alpha and interleukin-10 in protecting murine neonates from Escherichia coli sepsis.
    Lally KP, Cruz E, Xue H.
    J Pediatr Surg; 2000 Jun 15; 35(6):852-4; discussion 855. PubMed ID: 10873025
    [Abstract] [Full Text] [Related]

  • 10. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha.
    Doherty GM, Lange JR, Langstein HN, Alexander HR, Buresh CM, Norton JA.
    J Immunol; 1992 Sep 01; 149(5):1666-70. PubMed ID: 1506688
    [Abstract] [Full Text] [Related]

  • 11. The influence of antibodies to TNF-alpha and IL-1beta on haemodynamic responses to the cytokines, and to lipopolysaccharide, in conscious rats.
    Gardiner SM, Kemp PA, March JE, Woolley J, Bennett T.
    Br J Pharmacol; 1998 Dec 01; 125(7):1543-50. PubMed ID: 9884083
    [Abstract] [Full Text] [Related]

  • 12. Control of endotoxin shock by the dried preparation of low virulent Streptococcus pyogenes OK-432.
    Nose M, Uzawa A, Nomura M, Ikarashi Y, Nakata Y, Akashi M, Suzuki G.
    Cell Immunol; 1998 Sep 15; 188(2):97-104. PubMed ID: 9756639
    [Abstract] [Full Text] [Related]

  • 13. Peritoneal mesothelial cells produce inflammatory related cytokines.
    Yao V, Platell C, Hall JC.
    ANZ J Surg; 2004 Nov 15; 74(11):997-1002. PubMed ID: 15550091
    [Abstract] [Full Text] [Related]

  • 14. Treatment with Y-40138, a multiple cytokine production modulator, inhibits lipopolysaccharide- or tumour necrosis factor-alpha-induced production of pro-inflammatory cytokines and augments interleukin-10.
    Fukuda T, Hisadome M, Komatsu H.
    J Pharm Pharmacol; 2005 Nov 15; 57(11):1461-6. PubMed ID: 16259779
    [Abstract] [Full Text] [Related]

  • 15. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model.
    Pallua N, Low JF, von Heimburg D.
    Crit Care Med; 2003 May 15; 31(5):1495-501. PubMed ID: 12771624
    [Abstract] [Full Text] [Related]

  • 16. IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice.
    Tsutsui H, Matsui K, Kawada N, Hyodo Y, Hayashi N, Okamura H, Higashino K, Nakanishi K.
    J Immunol; 1997 Oct 15; 159(8):3961-7. PubMed ID: 9378984
    [Abstract] [Full Text] [Related]

  • 17. Effective phage therapy is associated with normalization of cytokine production by blood cell cultures.
    Weber-Dabrowska B, Zimecki M, Mulczyk M.
    Arch Immunol Ther Exp (Warsz); 2000 Oct 15; 48(1):31-7. PubMed ID: 10722229
    [Abstract] [Full Text] [Related]

  • 18. Divergent effects of tumor necrosis factor-alpha and lymphotoxin-alpha on lethal endotoxemia and infection with live Salmonella typhimurium in mice.
    Dharmana E, Keuter M, Netea MG, Verschueren IC, Kullberg BJ.
    Eur Cytokine Netw; 2002 Oct 15; 13(1):104-9. PubMed ID: 11956028
    [Abstract] [Full Text] [Related]

  • 19. Administration of interleukin-10 at the time of priming protects Corynebacterium parvum-primed mice against LPS- and TNF-alpha-induced lethality.
    Smith SR, Terminelli C, Denhardt G, Narula S, Thorbecke GJ.
    Cell Immunol; 1996 Nov 01; 173(2):207-14. PubMed ID: 8912878
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.